These prominent AMERICAN institutions and organizations are signaling a growing consensus that OGM isn’t just a research tool; it’s a clinical game-changer:

MD ANDERSON CANCER CENTER has integrated Bionano’s OGM into its Advanced Technology Genomics Core.

COLUMBIA UNIVERSITY MEDICAL CENTER is a key academic voice.

GREENWOOD GENETIC CENTER led by Dr. Roger Stevenson, has used OGM and, emphasizes its diagnostic clarity.

The COLLEGE of AMERICAN PATHOLOGISTS has also spotlighted OGM’s potential, noting its superior resolution and ability to detect structural variants that traditional methods often miss. They describe it as a transformative tool bridging discovery and diagnostics.

JOHNS HOPKINS DEP’T of PATHOLOGY presented a study on multiple myeloma showing that OGM revealed a more comprehensive genome-wide profile than traditional methods like FISH and karyotyping

Is the FDA paying attention or playing politics?